{"lastClose": 34.099998474121094, "len": 296, "date": "2023-03-14", "alpha_1": 3.0474937613488597, "beta_1": 1.0174969741086224, "drawup_1": 4.9751826094910365, "sharpe_1": 0.7739695054419541, "natr_1": 6.394254431236841, "sup_1": -0.15459428660496763, "res_1": 0.0059140488631792155, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 39.58523447770397, "adx_1": 16.627676209586813, "drawdown_1": -0.7260000038146972, "stratHoldSharpe_1": 0.7649357168198097, "stratHoldAlpha_1": 251.710389035758, "stratHoldDrawdown_1": -0.6537922778023011, "alpha_3mo": -0.22486891297279876, "beta_3mo": 1.5147666687179548, "drawup_3mo": 0.2298678427427674, "natr_3mo": 6.394254431236841, "sup_3mo": -0.06373412267365902, "res_3mo": 0.025024452471592133, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 43.64980680733391, "adx_3mo": 42.66010167010096, "drawdown_3mo": -0.25091620770071155, "stratHoldSharpe_3mo": 0.04819102746308537, "stratHoldAlpha_3mo": 251.02443961558987, "stratHoldDrawdown_3mo": -0.22913310539589826, "Country": "United States", "Industry": "Biotechnology: Pharmaceutical Preparations", "Name": "Amylyx Pharmaceuticals Inc.", "Sector": "Health Care", "Market Cap": 2259337034, "IPO Year": 2022.0, "alpha%_1": 1.0, "beta%_1": 0.5322680994355371, "drawup%_1": 1.0, "sharpe%_1": 0.5969421932834155, "natr%_1": 0.8102180580919571, "drawdown%_1": 0.036036168783345944, "stratHoldSharpe%_1": 0.8125860400285232, "stratHoldAlpha%_1": 0.994415707520465, "stratHoldDrawdown%_1": 0.042773001240567314, "alpha%_3mo": 0.22487880755285183, "beta%_3mo": 0.8236875962186899, "drawup%_3mo": 0.45507919444200606, "natr%_3mo": 0.805913692187568, "drawdown%_3mo": 0.21398929298747643, "stratHoldSharpe%_3mo": 0.45424543485151253, "stratHoldAlpha%_3mo": 0.47567017171564263, "stratHoldDrawdown%_3mo": 0.21580897672430716}